These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9572089)

  • 1. The dexamethasone suppression test in schizophrenia.
    Ismail K; Murray RM; Wheeler MJ; O'Keane V
    Psychol Med; 1998 Mar; 28(2):311-7. PubMed ID: 9572089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative and depressive symptoms in suicidal schizophrenics.
    Jones JS; Stein DJ; Stanley B; Guido JR; Winchel R; Stanley M
    Acta Psychiatr Scand; 1994 Feb; 89(2):81-7. PubMed ID: 8178667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J; Linka M; Matkowski K; Kanarkowski R
    Psychiatr Pol; 1991; 25(5):9-15. PubMed ID: 1821997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppression test and suicide attempts in schizophrenic patients.
    Płocka-Lewandowska M; Araszkiewicz A; Rybakowski JK
    Eur Psychiatry; 2001 Nov; 16(7):428-31. PubMed ID: 11728857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dexamethasone suppression test and negative symptoms of schizophrenia.
    McGauley GA; Aldridge CR; Fahy TA; Eastment C
    Acta Psychiatr Scand; 1989 Dec; 80(6):548-53. PubMed ID: 2618777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between depression and the dexamethasone suppression test following alcohol withdrawal in a psychiatric population.
    Johnson B; Perry JC
    J Clin Psychopharmacol; 1986 Dec; 6(6):343-9. PubMed ID: 3805327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the best screening test for depression in chronic spinal pain patients?
    Choi Y; Mayer TG; Williams MJ; Gatchel RJ
    Spine J; 2014 Jul; 14(7):1175-82. PubMed ID: 24225008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia.
    Newcomer JW; Faustman WO; Yeh W; Csernansky JG
    Psychiatry Res; 1990 Mar; 31(3):243-50. PubMed ID: 2333356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A; Alcser K; Grunhaus L; Greden JF
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and the dexamethasone suppression test (DST) in patients with non-specific somatic complaints. Atypical depression and DST.
    Syvälahti E; Hyyppä MT; Salminen JK
    Ann Clin Res; 1985; 17(4):148-51. PubMed ID: 4073803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test in a group of research diagnostic criteria schizoaffective depressed men.
    Wahby VS; Ibrahim GA; Giller EL; Saddik FW; Mason JW; Adams JR
    Neuropsychobiology; 1990-1991; 23(3):129-33. PubMed ID: 2098669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone suppression test in first-episode schizophrenia.
    Cesková E; Kaspárek T; Zourková A; Prikryl R
    Neuro Endocrinol Lett; 2006 Aug; 27(4):433-7. PubMed ID: 16892008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-dexamethasone cortisol as a predictor for the efficacy of electroconvulsive therapy in depressed inpatients.
    Vukadin M; Birkenhäger TK; Wierdsma AI; Groenland TH; van den Broek WW
    J Psychiatr Res; 2011 Sep; 45(9):1165-9. PubMed ID: 21481419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in affective illnesses and schizophrenia: relationship with psychotic symptoms.
    Hubain PP; Simonnet MP; Mendlewicz J
    Neuropsychobiology; 1986; 16(2-3):57-60. PubMed ID: 3587576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: a confirmatory report.
    Cottraux JA; Bouvard M; Claustrat B; Juenet C
    Psychiatry Res; 1984 Oct; 13(2):157-65. PubMed ID: 6596583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.